Visionquest Biomedical Inc.

Visionquest Biomedical Inc. is a corporate entity registered in SAM.gov, located in Albuquerque, New Mexico, with a business structure that includes self-certification as a small disadvantaged and veteran-owned business. The company appears to specialize in developing advanced medical technology solutions, particularly focusing on innovative diagnostic and screening technologies for various medical conditions, with a strong emphasis on diabetes-related healthcare technologies. Their work centers on creating software applications, imaging systems, and AI-driven diagnostic tools that aim to improve early detection and screening capabilities for complex medical conditions.

Through federal grant awards from agencies like the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Eye Institute, and National Institute of Allergy and Infectious Diseases, Visionquest Biomedical Inc. has developed several targeted technological solutions. These include EyeStar-BIO (software for enhancing digital binocular indirect ophthalmoscopy examinations), DR-SCRN (an electronic health record-integrated application for improving diabetic retinopathy screening compliance), i-RxTherm (a thermal imaging device for detecting diabetic peripheral neuropathy), and ASPIRE (an automated malarial retinopathy screening system for improved cerebral malaria diagnosis). Each project demonstrates the company's commitment to creating low-cost, technologically advanced screening and diagnostic tools that address specific healthcare challenges, with a particular focus on improving medical access for underserved populations and leveraging artificial intelligence and innovative imaging technologies to enhance medical diagnostic capabilities.